Latest Contracts News

ASX Limited reported a robust FY25 with revenue and underlying profit growth, while navigating regulatory scrutiny following a major settlement incident. The company advances its technology transformation and sustainability agenda as it seeks to rebuild trust and deliver shareholder value.

Articore Group Limited reported a notable turnaround in FY25 with improved margins and its first profitable quarter in five years, setting the stage for positive EBIT in FY26. The company’s strategic restructuring and supply chain efficiencies underpin cautious optimism for growth.

Ventia reported solid HY25 results with profit growth and a 43% dividend increase, underpinned by major contract wins and an upgraded FY25 outlook.

Burgundy Diamond Mines reported a mixed Q2-2025 with increased ore mined and carats recovered but lower revenue and earnings, prompting a strategic pivot including placing Point Lake on care and maintenance and extending Misery mine life.

Ventia Services Group has upgraded its FY25 profit guidance following a strong first half marked by record contract wins and an expanded share buyback program.

Ventia Services Group reported a 32.6% jump in half-year profit to $134.5 million despite a slight 1.5% revenue decline, declaring a 10.71 cents interim dividend and upgrading full-year earnings guidance.

Origin Energy reported a solid FY25 with strong Energy Markets performance, robust LNG trading gains, and rapid customer growth at Octopus Energy, while declaring a fully franked 60 cent dividend for the year.

Origin Energy reported a rise in statutory and underlying profits for FY25, driven by strong LNG trading gains that balanced softer Energy Markets earnings. The company also increased its fully franked dividend and outlined a positive outlook for FY26.

Euro Manganese Inc. has bolstered its development of the Chvaletice Manganese Project with new financing and critical regulatory approvals, while progressing offtake discussions amid ongoing market uncertainties.

InFocus Group Holdings addresses ASX concerns over a former director's non-disclosure of trading activity and provides detailed due diligence on key contract counterparties.

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.

Eildon Capital Group has entered a joint venture to acquire a large sandalwood plantation in Queensland’s Burdekin Irrigation District, while unveiling a strategic update to its operating model aimed at driving disciplined growth and enhanced returns.